Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

37 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Intraoperative opioid exposure, tumour genomic alterations, and survival differences in people with lung adenocarcinoma.
Connolly JG, Tan KS, Mastrogiacomo B, Dycoco J, Caso R, Jones GD, McCormick PJ, Sanchez-Vega F, Irie T, Scarpa JR, Gupta HV, Adusumilli PS, Rocco G, Isbell JM, Bott MJ, Fischer GW, Jones DR, Mincer JS. Connolly JG, et al. Among authors: dycoco j. Br J Anaesth. 2021 Jul;127(1):75-84. doi: 10.1016/j.bja.2021.03.030. Br J Anaesth. 2021. PMID: 34147159 Free PMC article.
Patterns of recurrence and incidence of second primary tumors after lobectomy by means of video-assisted thoracoscopic surgery (VATS) versus thoracotomy for lung cancer.
Flores RM, Ihekweazu UN, Rizk N, Dycoco J, Bains MS, Downey RJ, Adusumilli P, Finley DJ, Huang J, Rusch VW, Sarkaria I, Park B. Flores RM, et al. Among authors: dycoco j. J Thorac Cardiovasc Surg. 2011 Jan;141(1):59-64. doi: 10.1016/j.jtcvs.2010.08.062. Epub 2010 Nov 5. J Thorac Cardiovasc Surg. 2011. PMID: 21055770 Free article.
Distinct clinical course of EGFR-mutant resected lung cancers: results of testing of 1118 surgical specimens and effects of adjuvant gefitinib and erlotinib.
D'Angelo SP, Janjigian YY, Ahye N, Riely GJ, Chaft JE, Sima CS, Shen R, Zheng J, Dycoco J, Kris MG, Zakowski MF, Ladanyi M, Rusch V, Azzoli CG. D'Angelo SP, et al. Among authors: dycoco j. J Thorac Oncol. 2012 Dec;7(12):1815-1822. doi: 10.1097/JTO.0b013e31826bb7b2. J Thorac Oncol. 2012. PMID: 23154553 Free article.
Cell cycle progression score is a marker for five-year lung cancer-specific mortality risk in patients with resected stage I lung adenocarcinoma.
Eguchi T, Kadota K, Chaft J, Evans B, Kidd J, Tan KS, Dycoco J, Kolquist K, Davis T, Hamilton SA, Yager K, Jones JT, Travis WD, Jones DR, Hartman AR, Adusumilli PS. Eguchi T, et al. Among authors: dycoco j. Oncotarget. 2016 Jun 7;7(23):35241-56. doi: 10.18632/oncotarget.9129. Oncotarget. 2016. PMID: 27153551 Free PMC article.
37 results